We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
-3.86%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$312M
AUM Growth
-$9.44M
Cap. Flow
+$91.4M
Cap. Flow %
29.26%
Top 10 Hldgs %
89.79%
Holding
29
New
5
Increased
4
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$61.3M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$19.1M
3
RANI icon
Rani Therapeutics
RANI
+$8.54M
4
VIR icon
Vir Biotechnology
VIR
+$3.96M
5
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
+$757K

Top Sells

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$2.46M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 67.1%
2 Financials 30.02%
3 Communication Services 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
26
DELISTED
Synlogic
SYBX
$209K 0.07%
4,576
– –
DYN icon
27
Dyne Therapeutics
DYN
$4.9B
$189K 0.06%
+11,629
New +$206K
AKRO
28
DELISTED
Akero Therapeutics
AKRO
$78K 0.03%
3,470
– –
ARDX icon
29
Ardelyx
ARDX
$997M
– –
-325,233
Closed -$2.46M
1
2

Similar funds

MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
MW
Merited Wealth North Bay Village, Florida $121M AUM

Nan Fung Group Holdings's Q3 2021 Portfolio in Review

As of Q3 2021, Nan Fung Group Holdings held 29 positions worth $312M, down 2.9% from $322M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Nan Fung Group Holdings deployed $91.4M of net new capital in Q3 2021, opening 5 new positions and adding to 4 existing holdings. Its largest new stake was Illumina: 133,277 shares worth $52.6M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 68% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Sierra Oncology, Inc. Common Stock, an estimated $1.56M trimmed.

  • Nan Fung Group Holdings's largest Q3 2021 buy was Illumina: 133,277 shares worth $52.6M.
  • Nan Fung Group Holdings added most to Vir Biotechnology in Q3 2021, an estimated $3.96M increase.
  • Nan Fung Group Holdings's biggest Q3 2021 reduction was Sierra Oncology, Inc. Common Stock, cutting an estimated $1.56M.
  • Nan Fung Group Holdings fully exited Ardelyx in Q3 2021, selling an estimated $2.46M.
  • Nan Fung Group Holdings's ten largest holdings make up 90% of its $312M portfolio in Q3 2021.
  • Nan Fung Group Holdings opened 5 new positions and closed 1 in Q3 2021.
  • Nan Fung Group Holdings's portfolio value fell 2.9% quarter-over-quarter to $312M.

Based on Nan Fung Group Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.